Showing results (181-190 of 230) with videos related to
Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2006
Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancerHannah M Linden, Svetlana A Stekhova, Jeanne M Link, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 31, 2015
Castration-resistant prostate cancer bone metastasis response measured by 18F-fluoride PET after treatment with dasatinib and correlation with progression-free survival: results from American College of Radiology Imaging Network 6687Evan Y Yu, Fenghai Duan, Mark Muzi, et al.Cancer Discovery|December 10, 2025
Residual Breast Cancer Cells Co-opt SOX5-driven Endochondral Ossification to Maintain DormancyAmulya Sreekumar, Eric Blankemeyer, Christopher J Sterner, et al.Molecular Imaging and Biology|May 14, 2025
[18 F]-Fluoroestradiol PET (FES-PET) and [18 F] Flurodeoxyglucose PET (FDG-PET) Imaging May Aid in Managing Therapy in Patients with Metastatic Lobular Breast CancerPoorni M Manohar, Lanell M Peterson, Isaac C Jenkins, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 28, 2020
18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2- Metastatic Breast CancerLanell M Peterson, Brenda F Kurland, Fengting Yan, et al.Breast Cancer Research : BCR|August 24, 2021
18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity studyPerrin E Romine, Lanell M Peterson, Brenda F Kurland, et al.Blood|June 12, 2009
Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primatesDamian J Green, John M Pagel, Eneida R Nemecek, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancerHannah M Linden, Brenda F Kurland, Lanell M Peterson, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2015
A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688Lale Kostakoglu, Fenghai Duan, Michael O Idowu, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2021
Kinetic and Static Analysis of Poly-(Adenosine Diphosphate-Ribose) Polymerase-1-Targeted 18F-Fluorthanatrace PET Images of Ovarian CancerAnthony J Young, Austin R Pantel, Varsha Viswanath, et al.Pageof 23